Fagron N.V. : Further cementing its one-stop shop strategy in EMEA
>1Q22 recap: EMEA surprisingly strong - Fagron saw a strong start to the year, with a 4% sales beat on company-compiled consensus. EMEA was particularly impressive (5% ahead of cons), mainly driven by strong Essentials sales. Fagron continued its shopping spree in 1Q22, acquiring two companies (in Germany and NL) active in E&B and compounding services (AAOBe: combined <€8m sales). The company released qualitative FY22 guidance (group sales and absolute profitability g...Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.